Ambrx Biopharma Inc (AMAM)

Form 15-12G - Securities registration termination [Section 12(g)]

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form POS AM - Post-Effective amendments for registration statement

Form 8-K - Current report

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to Contact Law Firm

Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to Contact Law Firm PR Newswire NEW YORK, Feb. 12...